We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 0.49% | 203.50 | 201.00 | 203.00 | 207.50 | 200.00 | 200.00 | 388,249 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 27.73 | 440.94M |
From May 2019 to May 2024
TIDMAMS
RNS Number : 3058L
Advanced Medical Solutions Grp PLC
18 April 2018
Hot Features
Premium
18 April 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors and PDMRs under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 13 April 2018. The vesting period of these options is subject to certain performance criteria over a three year period.
Director/PDMR Options prior Options granted Resultant holding
to grant
Chris Meredith
Chief Executive
Officer 421,440 90,344 511,784
============== ================ ==================
Mary Tavener
Chief Financial
Officer 327,825 69,888 397,713
============== ================ ==================
Simon Coates
PDMR 69,524 14,751 84,275
============== ================ ==================
Rose Guang
PDMR 143,355 19,844 163,199
============== ================ ==================
Eddie Johnson
PDMR 89,158 19,603 108,761
============== ================ ==================
Pieter van Hoof
PDMR 89,641 18,659 108,300
============== ================ ==================
Rebecca Walmsley
PDMR 73,082 19,032 92,114
============== ================ ==================
Jeffrey Willis
PDMR 126,031 30,647 156,678
============== ================ ==================
Cathy Tomlinson
PDMR Nil 18,383 18,383
============== ================ ==================
Advanced Medical Solutions Group plc also announces that on 13 April 2018, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors under the Advanced Medical Solutions Deferred Annual Bonus Plan (the '2014 DAB').
This award is in respect of the part of their bonus that the Directors and PDMRs are compulsorily required to defer for the 2017 financial year. These options vest at the end of three years.
Director/PDMR Options prior Options granted Resultant holding
to grant
Chris Meredith
Chief Executive
Officer 83,384 21,749 105,133
============== ================ ==================
Mary Tavener
Chief Financial
Officer 55,728 14,021 69,749
============== ================ ==================
Simon Coates
PDMR 7,744 3,117 10,861
============== ================ ==================
Rose Guang
PDMR 17,198 4,072 21,270
============== ================ ==================
Eddie Johnson
PDMR 16,244 4,089 20,333
============== ================ ==================
Pieter van Hoof
PDMR 14,826 3,983 18,809
============== ================ ==================
Rebecca Walmsley
PDMR 5,181 3,483 8,664
============== ================ ==================
Jeffrey Willis
PDMR 21,094 5,950 27,044
============== ================ ==================
Cathy Tomlinson
PDMR Nil 2,573 2,573
============== ================ ==================
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 90,344 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 21,749 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Mary Tavener
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 69,888 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 14,021 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Simon Coates
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 14,751 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 3,117 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Rose Guang
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 19,844 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 4,072 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Eddie Johnson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 19,603 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 4,089 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Pieter van Hoof
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 18,659 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 3,983 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Rebecca Walmsley
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 19,032 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 3,483 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Jeffrey Willis
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 30,647 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 5,950 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Cathy Tomlinson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 18,383 options under the Advanced Medical
Solutions Long Term Incentive Plan on 13 April 2018
* Grant of 2,573 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 13 April 2018
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 13/04/2018
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Philippa AMS@consilium-comms.com
Gardner
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Patrick Robb / Gary Clarence
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFSTSFITLIT
(END) Dow Jones Newswires
April 18, 2018 04:45 ET (08:45 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
